Fundamental improvements to the well proven amaZon platform offer dramatically enhanced speed, and mass resolution. MS/MS efficiency and reproducible quantitation, are delivering unsurpassed performance levels. With a 10x higher MS/MS sensitivity over current platforms, Zero Delay Alternating™ switching at a minimum of 20 Hz MS acquisition rate, this ion trap meets the increasing demand of the pharmaceutical, chemical and clinical market.
amaZon builds upon Bruker’s vast experience in ion trap technology, and is designed specifically to enhance capabilities in research areas such as proteomics, metabolomics, compound screening and identification, and detailed chemical analysis.